1. Home
  2. FDMT vs NMFC Comparison

FDMT vs NMFC Comparison

Compare FDMT & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$10.21

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Logo New Mountain Finance Corporation

NMFC

New Mountain Finance Corporation

N/A

Current Price

$6.38

Market Cap

636.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FDMT
NMFC
Founded
2013
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
695.3M
636.6M
IPO Year
2019
2010

Fundamental Metrics

Financial Performance
Metric
FDMT
NMFC
Price
$10.21
$6.38
Analyst Decision
Strong Buy
Hold
Analyst Count
12
7
Target Price
★ $28.09
$8.13
AVG Volume (30 Days)
★ 855.5K
705.5K
Earning Date
11-12-2026
11-02-2026
Dividend Yield
N/A
★ 15.60%
EPS Growth
★ 18.79
N/A
EPS
N/A
★ N/A
Revenue
★ $85,209,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.79
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 230194.60
N/A
52 Week Low
$6.96
$6.31
52 Week High
$16.93
$9.84

Technical Indicators

Market Signals
Indicator
FDMT
NMFC
Relative Strength Index (RSI) 37.51 31.37
Support Level $8.43 N/A
Resistance Level $10.61 $7.26
Average True Range (ATR) 0.85 0.17
MACD -0.15 -0.05
Stochastic Oscillator 1.07 10.00

Price Performance

Historical Comparison
FDMT
NMFC

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

Share on Social Networks: